v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses    
Research and development $ 26,711 $ 9,763
General and administrative 26,090 8,873
Total operating expenses 52,801 18,636
Loss from operations (52,801) (18,636)
Other income (loss)    
Change in fair value of simple agreements for future equity (27,864) (13,717)
Interest and dividend income 7,732 180
Total other income (loss) (20,132) (13,537)
Loss before income taxes (72,933) (32,173)
Income taxes (683) 0
Net loss $ (73,616) $ (32,173)
Net loss per share:    
Basic - Class A Common Stock (in dollars per share) $ (0.74) $ (0.47)
Diluted - Class A Common Stock (in dollars per share) $ (0.74) $ (0.47)
Weighted-average number of shares outstanding - basic - Class A Common Stock (in shares) 98,910,013 68,891,996
Weighted-average number of shares outstanding - diluted - Class A Common Stock (in shares) 98,910,013 68,891,996